Maculopapular erythema caused by previously used chemotherapy drugs after nivolumab treatment for malignant mesothelioma
Main Authors: | Junko Kanai, Sayuko Nagaoka, Yumeko Hayashi, Shujiro Hayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Journal of Cutaneous Immunology and Allergy |
Online Access: | https://doi.org/10.1002/cia2.12196 |
Similar Items
-
Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy
by: Sayuko Nagaoka, et al.
Published: (2022-06-01) -
Maculopapular Drug Eruption Caused by Finasteride: A Case Report
by: Jia H, et al.
Published: (2023-11-01) -
Histopathologic Features of Maculopapular Drug Eruption
by: Madison Ernst, et al.
Published: (2022-03-01) -
Cost-effectiveness analysis of nivolumab plus ipilimumab chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma
by: Liu Yang, et al.
Published: (2022-08-01) -
Erythema nodosum following COVID‐19 vaccination: A case report and literature review
by: Chisato Watanabe, et al.
Published: (2023-12-01)